Cargando…

Factors Associated with the Prescribing of High-Intensity Statins

In this study, we investigated the relationship between sociodemographic, clinical, anthropometric, and lifestyle characteristics and the type of statin prescribed for primary prevention of cardiovascular disease (CVD). We conducted an observational study in workers who began statin treatment. Stati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaure-Pardos, Armando, Malo, Sara, Rabanaque, María José, Arribas, Federico, Moreno-Franco, Belén, Aguilar-Palacio, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760403/ https://www.ncbi.nlm.nih.gov/pubmed/33260835 http://dx.doi.org/10.3390/jcm9123850

Ejemplares similares

Identifying Clusters of Adherence to Cardiovascular Risk Reduction Behaviors and Persistence with Medication in New Lipid-Lowering Drug Users. Impact on Healthcare Utilization
por: Malo, Sara, et al.
Publicado: (2021)

Effectiveness of Statins for Primary Prevention of Cardiovascular Disease in Low- and Medium-Risk Males: A Causal Inference Approach with Observational Data
por: Chaure-Pardos, Armando, et al.
Publicado: (2022)

New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease: The Impact of Treatment Persistence on Morbimortality. A Longitudinal Study
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2020)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

Co-prescription patterns of cardiovascular preventive treatments: a cross-sectional study in the Aragon worker’ health study (Spain)
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2019)

Evolution of Cardiovascular Risk Factors in a Worker Cohort: A Cluster Analysis
por: Castel-Feced, Sara, et al.
Publicado: (2021)

Pharmacological Primary Cardiovascular Prevention and Subclinical Atherosclerosis in Men: Evidence from the Aragon Workers’ Health Study
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2021)

Effect of patient and treatment factors on persistence with antihypertensive treatment: A population-based study
por: Malo, Sara, et al.
Publicado: (2021)

Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers
por: Lallana, María Jesús, et al.
Publicado: (2018)

Addendum: Lallana, M.J. et al. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers. 2018, 15, 1836
por: Lallana, María Jesús, et al.
Publicado: (2020)

Understanding the COVID-19 Pandemic in Nursing Homes (Aragón, Spain): Sociodemographic and Clinical Factors Associated With Hospitalization and Mortality
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2022)

Influence of cardiovascular risk factors and treatment exposure on cardiovascular event incidence: Assessment using machine learning algorithms
por: Castel-Feced, Sara, et al.
Publicado: (2023)

COVID-19 Inequalities: Individual and Area Socioeconomic Factors (Aragón, Spain)
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2021)

Consumo de medicamentos en población adulta: influencia del autoconsumo
por: Carrera-Lasfuentes, Patricia, et al.
Publicado: (2013)

Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS)
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2018)

Correction: Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS)
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2020)

Utilización de servicios sanitarios en ancianos (España 2006-2012): influencia del nivel de salud y de la clase social
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2016)

Understanding the Effect of Economic Recession on Healthcare Services: A Systematic Review
por: Recio, Raquel Sánchez, et al.
Publicado: (2022)

Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
por: Hartz, Ingeborg, et al.
Publicado: (2007)

Factors predicting statin prescribing for primary prevention: a historical cohort study
por: Finnikin, Samuel, et al.
Publicado: (2021)

Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
por: Kim, Byung Gyu, et al.
Publicado: (2023)

Evidence-Based Prescribing of Statins: A Developing World Perspective
por: Ong, H. T
Publicado: (2006)

Prescribing of Statins After Lower Extremity Revascularization Procedures in the US
por: Singh, Nikhil, et al.
Publicado: (2021)

The Prevalence of Potential Prescribing Omissions for Antiplatelets and Statins in Older Adults With Atherosclerotic Cardiovascular Disease
por: Alshehri, Samah, et al.
Publicado: (2023)

Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care
por: Pate, Alexander, et al.
Publicado: (2020)

Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January–May 2021, Aragon, Spain
por: del Cura-Bilbao, Alicia, et al.
Publicado: (2022)

Lichenoid drug eruption induced by pravastatin; it is possible to prescribe other statins?()
por: Navarro-Triviño, Francisco J., et al.
Publicado: (2023)

Cognitive Function Assessment in Patients on Moderate- or High-Intensity Statin Therapy
por: Roy, Satyajeet, et al.
Publicado: (2020)

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
por: Fleetcroft, Robert, et al.
Publicado: (2014)

Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
por: Elkomos, Mary, et al.
Publicado: (2022)

Assessment of Primary Care Appointment Times and Appropriate Prescribing of Statins for At-Risk Patients
por: Hare, Allison J., et al.
Publicado: (2021)

Lack of accurate evidence on non-statin medication in patients receiving high-intensity statin therapy: Re-evaluation of recommendations is needed
por: Demirci, Deniz, et al.
Publicado: (2018)

Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies
por: Ah, Young-Mi, et al.
Publicado: (2022)

Retrospective cohort study of statin prescribing for primary prevention among people living with HIV
por: Nardolillo, Joseph A, et al.
Publicado: (2021)

Impact of the Affordable Care Act's Physician Payments Sunshine Act on branded statin prescribing
por: Li, Jing, et al.
Publicado: (2022)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Key factors influencing the prescribing of statins: a qualitative study among physicians working in primary healthcare facilities in Indonesia
por: Irawati, Sylvi, et al.
Publicado: (2020)

Exploring the human factors of prescribing errors in paediatric intensive care units
por: Sutherland, Adam, et al.
Publicado: (2019)

Prescribed Versus Preferred Intensity Resistance Exercise in Fibromyalgia Pain
por: da Cunha Ribeiro, Roberta P., et al.
Publicado: (2018)

Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines
por: Shakur, Rameen, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vf0p5fg0l317qpsfkeqve64k06